Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PF-06939926
PF-06939926
Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment
Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment
Fierce Biotech
Pfizer
clinical trials
Duchenne Muscular Dystrophy
gene therapy
patient deaths
PF-06939926
Flag link:
FDA Grants Fast Track Designation to Pfizer's DMD Gene Therapy
FDA Grants Fast Track Designation to Pfizer's DMD Gene Therapy
BioSpace
Pfizer
fast track
FDA
Duchenne Muscular Dystrophy
PF-06939926
Flag link:
Safety questions linger as Pfizer preps Duchenne gene therapy for final test
Safety questions linger as Pfizer preps Duchenne gene therapy for final test
BioPharma Dive
Pfizer
gene therapy
Duchenne Muscular Dystrophy
PF-06939926
Flag link:
Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study
Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study
Yahoo/Zacks.com
Pfizer
DMD
Duchenne Muscular Dystrophy
clinical trials
gene therapy
PF-06939926
Flag link:
Pfizer Commences Ph Ib Trial With Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
Pfizer Commences Ph Ib Trial With Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
CP Wire
Pfizer
PF-06939926
Duchenne Muscular Dystrophy
gene therapy
Flag link:
